In this issue:
4D algorithm reduces use of ultrasonography for suspected DVT
Post-stroke thrombolytics safe for patients on NOACs
Posttraumatic pulmonary clots mostly de novo thrombi, not emboli
Anticoagulant therapy indicated for subsegmental PE
Thromboprophylaxis effective for VTE prevention in hospitalised COVID patients
NOACs preferred in patients with AF and bioprosthetic valves
Microlyse: a thrombolytic agent for clearance of microvascular thrombosis
Efanesoctocog alfa offers once-weekly dosing for haemophilia A
Potential biomarkers for cancer-associated VTE and death
Cardiovascular disease is a leading cause of mortality among iTTP survivors
Please login below to download this issue (PDF)